chrisvoncsefalvay/vaers-outcomes huggingface dataset:
WHOLE RIGHT ARM STARTED TINGLING FROM SHOULDER TO FINGERS; FINGERS NUMB; BICEP HURTS ALL ON THE INNER SIDE OF ARM; This spontaneous report received from a patient concerned a 57 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient was in good health and did not have any symptoms before the vaccination. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 12:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced whole right arm started tingling from shoulder to fingers. On APR-2021, the subject experienced fingers numb. On APR-2021, the subject experienced bicep hurts all on the inner side of arm. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from whole right arm started tingling from shoulder to fingers, fingers numb, and bicep hurts all on the inner side of arm. This report was non-serious.
Lost taste; Lost smell; Body aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost taste), ANOSMIA (Lost smell), MYALGIA (Body aches) and HEADACHE (Headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included GALCANEZUMAB (EMGALITY [GALCANEZUMAB]), RIZATRIPTAN BENZOATE (MAXALT), ESTRADIOL and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Body aches) and HEADACHE (Headache). On 12-Feb-2021, the patient experienced AGEUSIA (Lost taste) and ANOSMIA (Lost smell). The patient was treated with IBUPROFEN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; NAPROXEN at an unspecified dose and frequency; ASCORBIC ACID, ZINC GLUCONATE (VITAMIN C + ZINK KAPSELN) at an unspecified dose and frequency and GALPHIMIA GLAUCA, HISTAMINE HYDROCHLORIDE, LUFFA OPERCULATA, SULFUR (ZICAM ALLERGY RELIEF [GALPHIMIA GLAUCA;HISTAMINE HYDROCHLORIDE;LUFFA OPERCULATA;SULFUR]) at an unspecified dose and frequency. On 15-Feb-2021, AGEUSIA (Lost taste), ANOSMIA (Lost smell), MYALGIA (Body aches) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-054295, US-MODERNATX, INC.-MOD-2021-060723 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up information received on 13-JUL-2021 contains Non-significant Information.; Sender's Comments:  MOD21-054295:cross link case US-MODERNATX, INC.-MOD-2021-060723:case for events occurred after first dose
Information has been received from a consumer concerning her 12 months old daughter who "2 weeks ago", on approximately 29-DEC-2009 was vaccinated with a dose of VARIVAX (Merck) (lot number not reported). About 1 and 1/2 weeks after the vaccination, on approximately 09-JAN-2010 the patient developed a mark at the  injection site. It was a "wide red ring with a bump". The child was seen by doctor who said not related to VARIVAX (Merck). The mother believed it was because it was the exact spot where the vaccine was administered. At the time of the report, the patient had not recovered. No further information is available.
After the second dose, the patient experienced a sore arm until 09June2021; Line of bumps along arm; Red Bumps; Itchy Bumps; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red Bumps), PRURITUS (Itchy Bumps), SKIN MASS (Line of bumps along arm) and MYALGIA (After the second dose, the patient experienced a sore arm until 09June2021) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jun-2021, the patient experienced ERYTHEMA (Red Bumps) and PRURITUS (Itchy Bumps). On 15-Jun-2021, the patient experienced SKIN MASS (Line of bumps along arm). On an unknown date, the patient experienced MYALGIA (After the second dose, the patient experienced a sore arm until 09June2021). At the time of the report, ERYTHEMA (Red Bumps), PRURITUS (Itchy Bumps), SKIN MASS (Line of bumps along arm) and MYALGIA (After the second dose, the patient experienced a sore arm until 09June2021) outcome was unknown.            No concomitant medications were  provided No treatment medications were provided   This case was linked to MOD-2021-222102 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Non new information received
3 hrs p/being inoculated w/Hep B vax, pt had rash on rt arm, which shortly spread to lt arm & both legs; Rash comes & goes no temp;
Loss of appetite, Chills and sweats, fever, body aches and pains, dizziness, unable to sleep due to these side effects. Have not slept in 3 nights due to these symptoms. I've been in bed since Friday night.
Localized soreness; 3x3 1/2" area of firm swelling; redness; warm to the touch. Parent and school nurse have provided Tylenol and Advil and cold compress.
Information has been received from a physician and her office staff member concerning a 4 year old boy who on 22-MAY-2008 was vaccinated with the second dose of VARIVAX (Merck) 0.5ml subcutaneously (lot# was either 660219/0154X or 660280/1997U). The patient developed swelling with warmth and redness from shoulder to elbow after receiving VARIVAX (Merck). Subsequently, the patient recovered. The patient sought unspecified medical attention. This is one of several reports from the same source. Additional information is not expected.
Fever 101 for 2 days, irritable, crying, waking up in the Middle of the Night. Leg at injection site hot + hard. Tylenol given every 4 hours. 4-3006 gave Hib again. Medical error. Already Had 4 doses. 1/24/08-office records received-well baby visits with C/O tugging at ears seen by audiologist for C/O hearing problem, and cerumen impaction right ear. Per 60 day follow up: My son has vaccine induced autism. 1/15/2010 Developmental delay, poor socialization skills, poor communication skills and multiple allergies.
This spontaneous report as received from a pharmacist refers to 2 female patients of unknown age. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 22-SEP-2016, one patient was vaccinated with PNEUMOVAX 23 lot # L024132, expiry date: 21-JAN-2017 (dosing details were not reported) once subcutaneously/ intramuscularly. On 12-OCT-2016, the second female was vaccinated with PNEUMOVAX 23 lot#M000592, expiry date: 12-OCT-2017 (dosing details were not reported) once subcutaneously/ intramuscularly. Approximately in 2016, both the patients experienced redness, swelling, body aches, headache and tiredness after the vaccination. The patients did not seek any medical attention. No treatment was given for the events. The outcome of redness, swelling, body aches, headache and tiredness was reported as recovered/resolved. There were no product quality complaints (PQC) involved. Additional information has been requested.
Narrative: COVID infections following completion of COVID vaccine series 02/19/21 COVID vaccine dose #1 03/12/21 COVID vaccine dose #2 05/04/21 Pt presents to care team reporting feeling unbalanced; MD recommends referral to audiology and avoid excessive use of ETOH 08/01/21 Pt brought to ER by EMS due to near syncope, AF with RVR, and HR fluctuating from 80s to 140s; reports occasional dry cough but mainly asymptomatic; EKG atrial flutter, CT head wnl, CXT suggestive of obstructive lung disease but no infiltrate identified; COVID POSITIVE; admitted inpatient and treated with metoprolol succinate, pravastatin, rivaroxaban, diltiazem 08/02/21 Pt reports feeling well and denies any complaints; discharged home and instructed to increase metroprolol succinate to 100 mg twice daily 08/04/21 Pt reports feeling well but continues to have slight cough, no fever 08/06/21 Pt reports no symptoms and opts out of daily calls
Pt recvd 1st dose of Hep B vax on 5FEB92 & w/in hrs of receiving the inject pt exp generalized bloating, inability to urinate & swollen feet; pt seen by MD on 6FEB92;
The NP said cellulitis around the injection site. Red, swollen and hot to the touch, itchy. Prescribed antibiotics Kflex 500mg 1 tab bid x 7 days.
Chest pain, chest pressure, shortness of breath, dizziness, heart racing when I try to do any form of physical activity , headaches, lightheaded when standing up, extreme fatigue, lump feeling in my throat
I have been having chills, headaches and joint pains since 2/3/21.
A nurse reported the occurrence of a positive Hep B surface antigen result in a neonate of unspecified gender who was vaccinated w/Hep B vaccine recombinant (Engerix-B) for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were unknown. On an unspecified date, the subject received the first injection of Engerix-B. Subsequently, the subject tested positive for Hep B surface antigen.
Onset of Liver Disease (NASH) unknown cause. Chronic fatigue. Depression/Anxiety. Memory Loss. 1. unexplained Liver Damage 2. sleep disorder + fatigue 3. Depression  No one will take responsiblity for this & the medical costs incurred.
Pneumovax in left deltoid. 24 hours later, redness from injection site to 8 cm distal. Warm to touch.
swelling on dorsum of right hand, proximal to the 2,3,4, and 5 MCP joints.  No erythema, no itch, no pain.  FROM and normal strength.  No respiratory or CNS sxs.  Immunization given in the right arm.
pt recvd vax on 25OCT93 & 16FEB94 devel measles; No further details were provided;
Throbbing head ache each morning for 7 days. Responds to ibuprophen.
Tested NAAT positive for COVID 9/18/21 after being fully vaccinated.
patient had to be hospitalized after getting chills, a fever, severe diarrhea and vomiting 3 hours after receiving vaccination. Patient did not report having adverse reactions to previous flue shots at the time of visit, but his wife did report that he has severe reactions to the flu shot each year.
Generalized feeling of "warm abdomen" and metallic taste resolved during observation Observation, water VSS Discharged to home
Arm starts hurting; arm is really hurting; Arm is really sore; Headache; Felt hazy kind of like it was going to haze/I have like a haze, like I was in a haze; Joint pain/My joints are killing me; Tiredness/Don't feel real good; Get side effects from the flu shot, I get the flu right after getting flu shot; Dizzy/Got up from the chair and I got dizzy right away; Got warm/Felt very warm my arm started hurting me within half an hour; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ER2613), dose 1 via an unspecified route of administration on 24Mar2021 12:00 (at the age of 51-years-old) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included blood pressure, high cholesterol , Hashimoto's disease , anxiety and had had thyroid removal 4 years ago stage 1 and radiational chemo. Concomitant medications included fish oil, levothyroxine sodium (SYNTHROID) taken for hypothyroidism; losartan (LOSARTAN) taken for blood pressure,; paroxetine hydrochloride (GENRX PAROXETINE) taken for anxiety; probiotics (PROBIOTICS); colecalciferol (VITAMIN D 3) and  ascorbic acid (VITAMIN C ACID).  Patient experienced dizzy right away when she got up from chair, Her arm was hurt and felt warm within half an hour. Patient had headache and also reported that her joint was killing her. She was feeling tired and was not feeling real good. The got the flu right after getting flu shot. Treatment with Tylenol was taken for headache and arm starts hurting. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
pt recv vax 5DEC95 & 10MAR97 pt devel 10 chicken pox;
Sweating and severe diarrhea.  Arm where shot was administered developed a red welp size of half dollar and stayed for over a week and then turned brown.
ARM SORENESS; PARTIAL DOSE ADMINISTERED; THE NEEDLE LEAKED OFF; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced partial dose administered. On an unspecified date, the subject experienced the needle leaked off, and arm soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the partial dose administered, arm soreness and the needle leaked off was not reported. This report was non-serious.
45 min p/DTP/OPV crying, screaming not consolable lasted more than 2 hrs. In office, was fussy, but consolable. Only pertinent physical finding was hot, red area @ inject site in thigh /s sign of infection. tx cool compresses/Tylenol.
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported. On 03-JAN-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB(lot # R001529, expiration date: 07-NOV-2020, thimerosal free, strength, dose, frequency and route unknown) for prophylaxis (Incorrect product storage). No adverse effects were reported. The vaccines were exposed to temperature of 47 Fahrenheit (F) for 37 minutes. The temperature excursion was detected by a data logger. Previous temperature excursions were reported as 47 Fahrenheit (F) for 50 minutes. Sender's Comments: US-009507513-1901USA004786.
On Sunday evening started having severe stomach pain burning sensation from abdomen to my upper chest, uncontrollable throwing up and diarrhea  and pains in my back shoulder blade area as well as lightheadedness to the point of feeling faint . Was Unable to stand or sit with out extreme burning in the same areas listed above. Today the burning , back pain, and diarrhea  still exist but throwing up stopped yesterday after taking pepto , the diarrhea isn?t as intense but is still here . Back pain is still here and can?t move or lay or my side or stomach due to the burning in my lower abdomen as it longer goes up to my chest .
Chronic pain in limbs; weakness in limbs; blurred and darkened eyesight in left eye; joint and muscle pain; irregular gait; tremors in hands and legs; weakened grip strength; fatigue; mental confusion.
Information has been received from a registered nurse concerning an 11 month old patient who on 13-APR-2010 was vaccinated with the second dose of ROTATEQ (lot number not reported). There was no adverse effect reported. It was unknown if medical attention was sought. Additional information has been requested.
pt devel on lt arm w 5cmx5cm raised warm erythematous hard area. temp 97.8 put on med.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age with none pertinent medical history and none drug reactions or allergies. At the time of this report the patient was not pregnant. On 28-JUL-2014 the patient was vaccinated with ZOSTAVAX (0.65 ml, subcutaneous, anatomical location, lot number were not reported). None concomitant medications were reported. On 30-JUL-2014, reported as "two days later", the patient experienced redness at the injection site. There was no treatment given for the adverse event. None lab diagnostics studies were performed. The patient did not seek medical attention. The outcome of redness at the injection site was reported as not recovered. The relatedness between redness at the injection site and ZOSTAVAX was not reported. Additional information is not expected because the reported do not wish to be contacted.
received a Hiberix and Pediarix dose out of indication; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old male patient who received Hib (Hiberix) (batch number J4F4M, expiry date 21st March 2023) for prophylaxis.   Co-suspect products included DTPa-HBV-IPV (Pediarix) (batch number 5nn259, expiry date 5th October 2023) for prophylaxis and dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th March 2022, the patient received Hiberix, Pediarix and Pediarix Pre-Filled Syringe Device. On 15th March 2022, unknown after receiving Hiberix, Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional details were provided as follows: The age at vaccination was unknown, (it could be 10 or 11 years). The Health care professional reported that the patient received a Hiberix and Pediarix dose out of indication, which led to inappropriate age at vaccine administration. The reporter consented to follow up. The case has been linked with the cases US2022047762 and US2022047763 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022047762:Same reporter US-GLAXOSMITHKLINE-US2022047759:same reporter - FU1 - DELETED  US-GLAXOSMITHKLINE-US2022047764:same reporter - FU - DELETED US-GLAXOSMITHKLINE-US2022047763:same reporter
1st dose - 23Jan2021; 2nd dose-10Feb2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose - 23Jan2021; 2nd dose-10Feb2021) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L21B, 051F21A, 031M20A and 028L20A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: Flu shot (Patient had her flu shot sometime last year close to the date of the 1st booster but not at the same time) in 2021. Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Hypertension, Palpitation and Thyroid disorder. Concomitant products included LEVOTHYROXINE SODIUM (THYROXINE) for Thyroid disorder.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose - 23Jan2021; 2nd dose-10Feb2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose - 23Jan2021; 2nd dose-10Feb2021) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2022, Body temperature: 102 102F, 101 101F, 99.8 99.8F and 103 103F.         It was reported that patient did not have any Covid-19 diagnosis prior to or after getting the vaccine. It was stated that patient did not take any medications for fever and no treatment medications were provided.
Intermittent chest pain/palpitations. Treated with methylprednisolone x2 taper packs (4 mg).  Chest pain mostly resolve except occasional light chest pain with occasional light palpitations. Physical activity stopped.
right arm started to hurt/pain at the injection site; pain is felt from the shoulder down to the elbow area; pain is felt from the shoulder down to the elbow area; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th February 2020, the patient received the 2nd dose of Shingrix. On 15th February 2020, 2 days after receiving Shingrix, the patient experienced pain in arm, shoulder pain and pain in elbow. On an unknown date, the outcome of the pain in arm, shoulder pain and pain in elbow were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, shoulder pain and pain in elbow to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the right arm and her right arm started to hurt.  The pain was felt from the shoulder down to the elbow area. She described it as very, very sore. Consented to follow up.
Having reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Having reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Having reactions). At the time of the report, VACCINATION COMPLICATION (Having reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding this event has been provided at this time.  Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Symptoms of Guillain Barre disease, including difficulty talking. Slurred speech, difficulty articulating words. Incident passed within one day.
Patient states feeling dizzy and nauseated. Patient legs elevated and paramedics assess patient. Blood pressure checked by paramedics and was elevated. 2L oxygen was administered by paramedics via nasal cannula for 2 minutes.    After 5 minutes patient states feeling better. denies any any nausea and BP rechecked was within normal limits .
Red, hot, raised, and swollen around injection site (3 x 3 inches but blotchy), very tender 2 hours after injection
Information has been received from a physician concerning a 4 month old patient who was vaccinated with Rotateq (date not reported).  The physician reported that the patient had received the initial dose of vaccine at another office beyond 12 weeks of age.  No problems were reported.  A product quality complaint was not reported.  No further information was provided.  Additional information is not expected.
First shot, bruise on arm with pain, profuse sweating with fever. Side pain. Second shot, side ache, after about 5 days both arms were really sore like arthritis but  I dont have arthritis in my elbows or wrists and my arms dont normally hurt. Took naproxen, tried Tylenol but got a side ache.